The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Adjuvant Capital Management, Llc since 2023.
This trader's CIK number is 1935084.
At the time of last reporting, Adjuvant Capital Management, Llc was the Officer of An2 Therapeutics, Inc.. (stock ticker symbol ANTX).
Also see all insider trading activities at An2 Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ANTX | 0 | $0 | 100,000 | $1,964,999 | 0 | $0 |
| 2023 | ANTX | 0 | $0 | 123,880 | $2,011,726 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-16 | ANTX | Sale | 100,000 | 19.65 | 1,964,999 |
| 2023-11-14 | ANTX | Sale | 1,810 | 16.15 | 29,224 |
| 2023-10-02 | ANTX | Sale | 5,672 | 16.07 | 91,149 |
| 2023-09-29 | ANTX | Sale | 99,101 | 16.28 | 1,613,364 |
| 2023-09-27 | ANTX | Sale | 841 | 16.07 | 13,514 |
| 2023-09-28 | ANTX | Sale | 8,516 | 16.11 | 137,192 |
| 2023-09-13 | ANTX | Sale | 400 | 16.00 | 6,400 |
| 2023-09-06 | ANTX | Sale | 3,762 | 16.02 | 60,267 |
| 2023-09-07 | ANTX | Sale | 3,378 | 16.05 | 54,216 |
| 2023-08-23 | ANTX | Sale | 400 | 16.00 | 6,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Adjuvant Capital Management, Llc (Officer of An2 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.